The fda will reassign the original acronym to anot

Quote:

---

The fda will reassign the original acronym to another disease, immediately rendering all of our previous trials and protocols useless because they’re now for the wrong disease. We have to start over from phase 1 and the fda requests a type f(u) meeting to discuss what’s needed.

---

Unfortunately our requests for a meeting with the FDA will not be answered because the FDA has reassigned themselves a different name, the AFDA (Alcoholic Fatty Disease Anonymous). All communications to the agency under the old name have been redirected to the government agency called WDCWDHT (We Don't Care We Don't Have To) for further shelving.